DEBLOAT Superfood
DEBLOAT Superfood
Sold out
Regular price
Rs. 399.00
Regular price
Rs. 399.00
Sale price
Rs. 399.00
Shipping calculated at checkout.
Bloating? Relief begins with your gut.
This works from the inside out to ease cramps, heaviness, and digestive discomfort.
Targets inflammation, supports digestion, and reduces water retention, naturally.
100% plant-powered. No preservatives. No dependency.
Just a lighter, calmer, pain-free you.
Instant Cramp relief
Targets root causes
100% Plant actives
Quantity
Couldn't load pickup availability
Why you'll love it?
Why you'll love it?
How to use?
How to use?
Standards Complied
Standards Complied
Debloat Superfood works by reducing inflammation, improving digestion, releasing gas, balancing acidity, and supporting gut health, giving lighter stomach, smoother digestion, and reduced cramps.
Reduces gut inflammations
here plant bioactives calm this inflammation, helping the gut relax.
Improves digestion & speeds up movement of food
Helps your stomach and intestines break down food better and move it smoothly, reducing gas buildup, heaviness, discomfort after meals
Targets period-related bloating
by countering hormone-driven digestive slowdown.
Supports good gut bacteria
Plant fibres and phytonutrients act as prebiotics, feeding the good bacteria that maintain a healthy gut environment, reducing recurrent bloating over time.
Boosts Your Body’s Healing
Your body already knows how to heal; this superfood simply supports and speeds it up.
Reduces gut inflammations
here plant bioactives calm this inflammation, helping the gut relax.
Improves digestion & speeds up movement of food
Helps your stomach and intestines break down food better and move it smoothly, reducing gas buildup, heaviness, discomfort after meals
Targets period-related bloating
by countering hormone-driven digestive slowdown.
Supports good gut bacteria
Plant fibres and phytonutrients act as prebiotics, feeding the good bacteria that maintain a healthy gut environment, reducing recurrent bloating over time.
Boosts Your Body’s Healing
Your body already knows how to heal; this superfood simply supports and speeds it up.
FEATURES
✦
100% plant-active formula:
made from powerful, clean botanical extracts.
✦
Reduces bloating, gas, and heaviness:
through natural digestive support.
✦
Calms gut inflammation:
for smoother, more comfortable digestion.
✦
Balances acidity:
to reduce burning, discomfort, and indigestion.
✦
Supports healthy gut bacteria:
with prebiotic-rich ingredients.
✦
Reduces water retention:
helping the stomach feel lighter and less puffy.
✦
Eases period-related bloating by:
countering hormone-driven digestive slowdown.
✦
0 sugar, 0 additives:
clean, safe, daily-friendly formula.
✦
Fast-acting bioactive :
blend that starts working from the first use.
✦
Gentle on the stomach, suitable for long-term, everyday use.:
✦
Convenient single-dose format for easy daily intake.:
✦
Safe, plant-based alternative to antacids and chemical-heavy digestive aids.:
FEATURES
✦
100% plant-active formula:
made from powerful, clean botanical extracts.
✦
Reduces bloating, gas, and heaviness:
through natural digestive support.
✦
Calms gut inflammation:
for smoother, more comfortable digestion.
✦
Balances acidity:
to reduce burning, discomfort, and indigestion.
✦
Supports healthy gut bacteria:
with prebiotic-rich ingredients.
✦
Reduces water retention:
helping the stomach feel lighter and less puffy.
✦
Eases period-related bloating by:
countering hormone-driven digestive slowdown.
✦
0 sugar, 0 additives:
clean, safe, daily-friendly formula.
✦
Fast-acting bioactive :
blend that starts working from the first use.
✦
Gentle on the stomach, suitable for long-term, everyday use.:
✦
Convenient single-dose format for easy daily intake.:
✦
Safe, plant-based alternative to antacids and chemical-heavy digestive aids.:
FEATURES
✦
100% plant-active formula:
made from powerful, clean botanical extracts.
✦
Reduces bloating, gas, and heaviness:
through natural digestive support.
✦
Calms gut inflammation:
for smoother, more comfortable digestion.
✦
Balances acidity:
to reduce burning, discomfort, and indigestion.
✦
Supports healthy gut bacteria:
with prebiotic-rich ingredients.
✦
Reduces water retention:
helping the stomach feel lighter and less puffy.
✦
Eases period-related bloating by:
countering hormone-driven digestive slowdown.
✦
0 sugar, 0 additives:
clean, safe, daily-friendly formula.
✦
Fast-acting bioactive :
blend that starts working from the first use.
✦
Gentle on the stomach, suitable for long-term, everyday use.:
✦
Convenient single-dose format for easy daily intake.:
✦
Safe, plant-based alternative to antacids and chemical-heavy digestive aids.:
Summary of the studies conducted
| Study Name | Study Type / Model | Key Findings / Results | Conclusion / Outcome |
|---|---|---|---|
| 1. Skin Irritation Study | In-vivo (6 male Wistar rats) | Draize scores: 0.0-0.5; no erythema, edema, or irritation observed; normal histopathology | Non-irritant and well-tolerated upon repeated dermal exposure |
| 2. Carrageenan-Induced Paw Edema Study | In-vivo anti-inflammatory model (18 Wistar rats) | Significant reduction in paw edema vs control; inhibition comparable to NSAID reference drug | Confirms strong anti-inflammatory and prostaglandin-suppressing activity |
| 3. Acute Oral Toxicity Study | In-vivo (15 albino rats) | No mortality or systemic toxicity; normal histopathology and stable body weight | Safe at high oral doses; LD₅₀ exceeds tested limits |
| 4. Experimental Dysmenorrhea Rat Model | In-vivo (Oxytocin-induced uterine contraction model) | Significant reduction in writhing behavior and PGF₂α levels; superior to Mefatal-Spas | Demonstrated superior spasmolytic and prostaglandin-modulating action |
| 5. Human Pilot Study - Cramp Relief Gel & Debloat Superfood (n = 90) | Randomized controlled pilot (90 women, 3 cycles) | Onset of action within 10-30 sec; 90% achieved >80% pain reduction; no side effects | Significantly faster, safer, and more effective than NSAIDs and home remedies |
| 6. In-vitro Dissolution Study | Simulated vaginal fluid (SVF) | Rapid release within 1 min; sustained release up to 8 hrs; diffusion-controlled mechanism (R² ≈ 0.98) | Optimized biphasic release ensuring instant + long-lasting relief |
| 7. Vaginal Irritation Study | In-vivo (New Zealand white rabbits) | No erythema, edema, or abnormal discharge; normal histopathology | Classified as non-irritant to vaginal mucosa; highly biocompatible |
| 8. Cytotoxicity Study (L929 Fibroblasts) | In-vitro cell viability assay | >90% cell viability across all concentrations; normal morphology | Non-cytotoxic; safe for dermal and mucosal contact |
| 9. Skin Sensitization Study | In-vivo (Wistar rats, ISO 10993-10) | No erythema, edema, or lymphoid activation; histopathology normal | Non-sensitizing and safe for prolonged dermal use |
| 10. Therapeutic Efficacy in Dysmenorrhea Model | In-vivo (Rat model) | Reduced writhing, normalized uterine histology; PGF₂α ↓ to 35-40 ng/mL, PGE₂ undetectable, TNF-α < assay detection | Potent anti-dysmenorrheic efficacy; equal or greater than NSAIDs |
| 11. Anti-Inflammatory Evaluation (Carrageenan Model) | In-vivo (Rat model, ISO 10993-11) | 65.36% inhibition of inflammation at 6 h (NSAID: 118.79%); p < 0.01 | Strong topical anti-inflammatory action validating NSAID-like efficacy |
| 12. Human Observational Study- Sanitary Pad (n=30) | Prospective open-label, 3 menstrual cycles | Pain reduced from VAS 7.4 → 2.1 (p < 0.001); >70% reduction in bloating; 87% strong user preference; no AEs | Clinically effective, safe, and well-tolerated; improved comfort and function |
Note:
All studies were done ethically, with expert supervision, and only for required safety checks.
No animals were harmed; every animal used in testing remained alive, safe, and healthy
throughout the process.
Summary of the studies conducted
| Study Name | Study Type / Model | Key Findings / Results | Conclusion / Outcome |
|---|---|---|---|
| 1. Skin Irritation Study | In-vivo (6 male Wistar rats) | Draize scores: 0.0-0.5; no erythema, edema, or irritation observed; normal histopathology | Non-irritant and well-tolerated upon repeated dermal exposure |
| 2. Carrageenan-Induced Paw Edema Study | In-vivo anti-inflammatory model (18 Wistar rats) | Significant reduction in paw edema vs control; inhibition comparable to NSAID reference drug | Confirms strong anti-inflammatory and prostaglandin-suppressing activity |
| 3. Acute Oral Toxicity Study | In-vivo (15 albino rats) | No mortality or systemic toxicity; normal histopathology and stable body weight | Safe at high oral doses; LD₅₀ exceeds tested limits |
| 4. Experimental Dysmenorrhea Rat Model | In-vivo (Oxytocin-induced uterine contraction model) | Significant reduction in writhing behavior and PGF₂α levels; superior to Mefatal-Spas | Demonstrated superior spasmolytic and prostaglandin-modulating action |
| 5. Human Pilot Study - Cramp Relief Gel & Debloat Superfood (n = 90) | Randomized controlled pilot (90 women, 3 cycles) | Onset of action within 10-30 sec; 90% achieved >80% pain reduction; no side effects | Significantly faster, safer, and more effective than NSAIDs and home remedies |
| 6. In-vitro Dissolution Study | Simulated vaginal fluid (SVF) | Rapid release within 1 min; sustained release up to 8 hrs; diffusion-controlled mechanism (R² ≈ 0.98) | Optimized biphasic release ensuring instant + long-lasting relief |
| 7. Vaginal Irritation Study | In-vivo (New Zealand white rabbits) | No erythema, edema, or abnormal discharge; normal histopathology | Classified as non-irritant to vaginal mucosa; highly biocompatible |
| 8. Cytotoxicity Study (L929 Fibroblasts) | In-vitro cell viability assay | >90% cell viability across all concentrations; normal morphology | Non-cytotoxic; safe for dermal and mucosal contact |
| 9. Skin Sensitization Study | In-vivo (Wistar rats, ISO 10993-10) | No erythema, edema, or lymphoid activation; histopathology normal | Non-sensitizing and safe for prolonged dermal use |
| 10. Therapeutic Efficacy in Dysmenorrhea Model | In-vivo (Rat model) | Reduced writhing, normalized uterine histology; PGF₂α ↓ to 35-40 ng/mL, PGE₂ undetectable, TNF-α < assay detection | Potent anti-dysmenorrheic efficacy; equal or greater than NSAIDs |
| 11. Anti-Inflammatory Evaluation (Carrageenan Model) | In-vivo (Rat model, ISO 10993-11) | 65.36% inhibition of inflammation at 6 h (NSAID: 118.79%); p < 0.01 | Strong topical anti-inflammatory action validating NSAID-like efficacy |
| 12. Human Observational Study- Sanitary Pad (n=30) | Prospective open-label, 3 menstrual cycles | Pain reduced from VAS 7.4 → 2.1 (p < 0.001); >70% reduction in bloating; 87% strong user preference; no AEs | Clinically effective, safe, and well-tolerated; improved comfort and function |
Note:
All studies were done ethically, with expert supervision, and only for required safety checks.
No animals were harmed; every animal used in testing remained alive, safe, and healthy
throughout the process.
Summary of the studies conducted
| Study Name | Study Type / Model | Key Findings / Results | Conclusion / Outcome |
|---|---|---|---|
| 1. Skin Irritation Study | In-vivo (6 male Wistar rats) | Draize scores: 0.0-0.5; no erythema, edema, or irritation observed; normal histopathology | Non-irritant and well-tolerated upon repeated dermal exposure |
| 2. Carrageenan-Induced Paw Edema Study | In-vivo anti-inflammatory model (18 Wistar rats) | Significant reduction in paw edema vs control; inhibition comparable to NSAID reference drug | Confirms strong anti-inflammatory and prostaglandin-suppressing activity |
| 3. Acute Oral Toxicity Study | In-vivo (15 albino rats) | No mortality or systemic toxicity; normal histopathology and stable body weight | Safe at high oral doses; LD₅₀ exceeds tested limits |
| 4. Experimental Dysmenorrhea Rat Model | In-vivo (Oxytocin-induced uterine contraction model) | Significant reduction in writhing behavior and PGF₂α levels; superior to Mefatal-Spas | Demonstrated superior spasmolytic and prostaglandin-modulating action |
| 5. Human Pilot Study - Cramp Relief Gel & Debloat Superfood (n = 90) | Randomized controlled pilot (90 women, 3 cycles) | Onset of action within 10-30 sec; 90% achieved >80% pain reduction; no side effects | Significantly faster, safer, and more effective than NSAIDs and home remedies |
| 6. In-vitro Dissolution Study | Simulated vaginal fluid (SVF) | Rapid release within 1 min; sustained release up to 8 hrs; diffusion-controlled mechanism (R² ≈ 0.98) | Optimized biphasic release ensuring instant + long-lasting relief |
| 7. Vaginal Irritation Study | In-vivo (New Zealand white rabbits) | No erythema, edema, or abnormal discharge; normal histopathology | Classified as non-irritant to vaginal mucosa; highly biocompatible |
| 8. Cytotoxicity Study (L929 Fibroblasts) | In-vitro cell viability assay | >90% cell viability across all concentrations; normal morphology | Non-cytotoxic; safe for dermal and mucosal contact |
| 9. Skin Sensitization Study | In-vivo (Wistar rats, ISO 10993-10) | No erythema, edema, or lymphoid activation; histopathology normal | Non-sensitizing and safe for prolonged dermal use |
| 10. Therapeutic Efficacy in Dysmenorrhea Model | In-vivo (Rat model) | Reduced writhing, normalized uterine histology; PGF₂α ↓ to 35-40 ng/mL, PGE₂ undetectable, TNF-α < assay detection | Potent anti-dysmenorrheic efficacy; equal or greater than NSAIDs |
| 11. Anti-Inflammatory Evaluation (Carrageenan Model) | In-vivo (Rat model, ISO 10993-11) | 65.36% inhibition of inflammation at 6 h (NSAID: 118.79%); p < 0.01 | Strong topical anti-inflammatory action validating NSAID-like efficacy |
| 12. Human Observational Study- Sanitary Pad (n=30) | Prospective open-label, 3 menstrual cycles | Pain reduced from VAS 7.4 → 2.1 (p < 0.001); >70% reduction in bloating; 87% strong user preference; no AEs | Clinically effective, safe, and well-tolerated; improved comfort and function |
Note:
All studies were done ethically, with expert supervision, and only for required safety checks.
No animals were harmed; every animal used in testing remained alive, safe, and healthy
throughout the process.
Summary of the studies conducted
| Study Name | Study Type / Model | Key Findings / Results | Conclusion / Outcome |
|---|---|---|---|
| 1. Skin Irritation Study | In-vivo (6 male Wistar rats) | Draize scores: 0.0-0.5; no erythema, edema, or irritation observed; normal histopathology | Non-irritant and well-tolerated upon repeated dermal exposure |
| 2. Carrageenan-Induced Paw Edema Study | In-vivo anti-inflammatory model (18 Wistar rats) | Significant reduction in paw edema vs control; inhibition comparable to NSAID reference drug | Confirms strong anti-inflammatory and prostaglandin-suppressing activity |
| 3. Acute Oral Toxicity Study | In-vivo (15 albino rats) | No mortality or systemic toxicity; normal histopathology and stable body weight | Safe at high oral doses; LD₅₀ exceeds tested limits |
| 4. Experimental Dysmenorrhea Rat Model | In-vivo (Oxytocin-induced uterine contraction model) | Significant reduction in writhing behavior and PGF₂α levels; superior to Mefatal-Spas | Demonstrated superior spasmolytic and prostaglandin-modulating action |
| 5. Human Pilot Study - Cramp Relief Gel & Debloat Superfood (n = 90) | Randomized controlled pilot (90 women, 3 cycles) | Onset of action within 10-30 sec; 90% achieved >80% pain reduction; no side effects | Significantly faster, safer, and more effective than NSAIDs and home remedies |
| 6. In-vitro Dissolution Study | Simulated vaginal fluid (SVF) | Rapid release within 1 min; sustained release up to 8 hrs; diffusion-controlled mechanism (R² ≈ 0.98) | Optimized biphasic release ensuring instant + long-lasting relief |
| 7. Vaginal Irritation Study | In-vivo (New Zealand white rabbits) | No erythema, edema, or abnormal discharge; normal histopathology | Classified as non-irritant to vaginal mucosa; highly biocompatible |
| 8. Cytotoxicity Study (L929 Fibroblasts) | In-vitro cell viability assay | >90% cell viability across all concentrations; normal morphology | Non-cytotoxic; safe for dermal and mucosal contact |
| 9. Skin Sensitization Study | In-vivo (Wistar rats, ISO 10993-10) | No erythema, edema, or lymphoid activation; histopathology normal | Non-sensitizing and safe for prolonged dermal use |
| 10. Therapeutic Efficacy in Dysmenorrhea Model | In-vivo (Rat model) | Reduced writhing, normalized uterine histology; PGF₂α ↓ to 35-40 ng/mL, PGE₂ undetectable, TNF-α < assay detection | Potent anti-dysmenorrheic efficacy; equal or greater than NSAIDs |
| 11. Anti-Inflammatory Evaluation (Carrageenan Model) | In-vivo (Rat model, ISO 10993-11) | 65.36% inhibition of inflammation at 6 h (NSAID: 118.79%); p < 0.01 | Strong topical anti-inflammatory action validating NSAID-like efficacy |
| 12. Human Observational Study- Sanitary Pad (n=30) | Prospective open-label, 3 menstrual cycles | Pain reduced from VAS 7.4 → 2.1 (p < 0.001); >70% reduction in bloating; 87% strong user preference; no AEs | Clinically effective, safe, and well-tolerated; improved comfort and function |
Note:
All studies were done ethically, with expert supervision, and only for required safety checks.
No animals were harmed; every animal used in testing remained alive, safe, and healthy
throughout the process.
HOW WE COMPARE
Reduces gut inflammation, easing pain, and discomfort at the root.
PAIN RELIEF
Most digestives only help with acidity or gas.
Plant actives, toxin-free, zero sugar, zero chemical/additives
SAFETY
Often contains chemicals, synthetic antacids or sodium bicarbonate
Effective for period cramps, acidity, aches due to digestive discomforts.
MULTI-USE
Mostly limited to laxative properties.
Faster relief, within 20-30 minutes.
SPEED
Relief is usually slower or very temporary.
100% natural, high-potency plant actives, gentle, safe, and designed for consistent use.
INGREDIENTS
Synthetic ingredients and many everyday digestives aren’t recommended long-term
Supports entire gut health.
ABSORPTION
Not full digestive support system.
Thoroughly tested for toxicity, actives compatibility, and clinical safety.
CLINICAL PROOF
Safety may not be as rigorously tested
WHY WOMEN PREFER
